Immix Biopharma is trading 5.93% higher at $11.62 on September 28, 2026; the catalyst remains unclear. - No clear company-specific announcement or catalyst was identified; available stock coverage also reported no new catalysts. - Broader markets were lower as rising oil prices and Treasury yields weighed on investor sentiment, but that direction does not explain the gain.